At a glance
ClinicalIndex Comparison RecordN/ACompleted· 995 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prediction of Recurrent Events With 18F-Fluoride to Identify Ruptured and High-risk Coronary Artery Plaques in Patients With Myocardial Infarction
In Brief
An observational study for Coronary Artery Disease and Myocardial Infarction. Completed, enrolled 995 participants across 1 site.
Detailed Summary
This is a multi-centre observational study. It will make use of the positron emission tomography (PET) tracer 18F-sodium fluoride (18F-NaF) as a marker of coronary plaque vulnerability to detect culprit and non-culprit unstable coronary plaques in patients with recent myocardial infarctions. The investigators will then perform long-term follow-up of these patients to determine the prognostic significance of coronary 18F-NaF uptake
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Myocardial Infarction
CountriesUnited Kingdom
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 2014
Enrollment StartOct 2015
Primary CompletionMar 2022
Study CompletionMay 2022
TodayJul 2026
First PostedOct 29, 2014
Enrollment StartOct 1, 2015
Primary CompletionMar 1, 2022
Study CompletionMay 1, 2022
TodayJul 2, 2026
Enrollment to primary: 6.4 yearsPosted 11.7 years ago